Pharma & Healthcare
Veterinary Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 554702
- Pages: 128
- Figures: 218
- Views: 1
Veterinary Therapeutics are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The global market for Veterinary Therapeutics was estimated to be worth US$ 23720 million in 2023 and is forecast to a readjusted size of US$ 34600 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030
North American market for Veterinary Therapeutics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Veterinary Therapeutics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Veterinary Therapeutics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Veterinary Therapeutics include Zoetis, Elanco, Boehringer Ingelheim, Merck, Virbac, Ceva, Vetoquinol, Dechra and Norbrook, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Veterinary Therapeutics by region & country, by Type, and by Application.
The Veterinary Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Therapeutics.
Market Segmentation
By Company
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur
Segment by Type:
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segment by Application
Pets
Cattle
Poultry
Swine
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Veterinary Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Veterinary Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Veterinary Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Veterinary Therapeutics was estimated to be worth US$ 23720 million in 2023 and is forecast to a readjusted size of US$ 34600 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030
North American market for Veterinary Therapeutics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Veterinary Therapeutics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Veterinary Therapeutics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Veterinary Therapeutics include Zoetis, Elanco, Boehringer Ingelheim, Merck, Virbac, Ceva, Vetoquinol, Dechra and Norbrook, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Veterinary Therapeutics by region & country, by Type, and by Application.
The Veterinary Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Therapeutics.
Market Segmentation
By Company
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur
Segment by Type:
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segment by Application
Pets
Cattle
Poultry
Swine
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Veterinary Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Veterinary Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Veterinary Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Veterinary Therapeutics Product Introduction
1.2 Global Veterinary Therapeutics Market Size Forecast
1.3 Veterinary Therapeutics Market Trends & Drivers
1.3.1 Veterinary Therapeutics Industry Trends
1.3.2 Veterinary Therapeutics Market Drivers & Opportunity
1.3.3 Veterinary Therapeutics Market Challenges
1.3.4 Veterinary Therapeutics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Veterinary Therapeutics Players Revenue Ranking (2023)
2.2 Global Veterinary Therapeutics Revenue by Company (2019-2024)
2.3 Key Companies Veterinary Therapeutics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Veterinary Therapeutics Product Offered
2.5 Key Companies Time to Begin Mass Production of Veterinary Therapeutics
2.6 Veterinary Therapeutics Market Competitive Analysis
2.6.1 Veterinary Therapeutics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Veterinary Therapeutics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Therapeutics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Anti-Infectives
3.1.2 Anti-Inflammatory
3.1.3 Parasiticides
3.1.4 Analgesics
3.1.5 Sedatives
3.1.6 Others
3.2 Global Veterinary Therapeutics Sales Value by Type
3.2.1 Global Veterinary Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Veterinary Therapeutics Sales Value, by Type (2019-2030)
3.2.3 Global Veterinary Therapeutics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pets
4.1.2 Cattle
4.1.3 Poultry
4.1.4 Swine
4.1.5 Others
4.2 Global Veterinary Therapeutics Sales Value by Application
4.2.1 Global Veterinary Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Veterinary Therapeutics Sales Value, by Application (2019-2030)
4.2.3 Global Veterinary Therapeutics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Veterinary Therapeutics Sales Value by Region
5.1.1 Global Veterinary Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Veterinary Therapeutics Sales Value by Region (2019-2024)
5.1.3 Global Veterinary Therapeutics Sales Value by Region (2025-2030)
5.1.4 Global Veterinary Therapeutics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Veterinary Therapeutics Sales Value, 2019-2030
5.2.2 North America Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Veterinary Therapeutics Sales Value, 2019-2030
5.3.2 Europe Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Veterinary Therapeutics Sales Value, 2019-2030
5.4.2 Asia Pacific Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Veterinary Therapeutics Sales Value, 2019-2030
5.5.2 South America Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Veterinary Therapeutics Sales Value, 2019-2030
5.6.2 Middle East & Africa Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Veterinary Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Veterinary Therapeutics Sales Value
6.3 United States
6.3.1 United States Veterinary Therapeutics Sales Value, 2019-2030
6.3.2 United States Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Veterinary Therapeutics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Veterinary Therapeutics Sales Value, 2019-2030
6.4.2 Europe Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Veterinary Therapeutics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Veterinary Therapeutics Sales Value, 2019-2030
6.5.2 China Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Veterinary Therapeutics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Veterinary Therapeutics Sales Value, 2019-2030
6.6.2 Japan Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Veterinary Therapeutics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Veterinary Therapeutics Sales Value, 2019-2030
6.7.2 South Korea Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Veterinary Therapeutics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Veterinary Therapeutics Sales Value, 2019-2030
6.8.2 Southeast Asia Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Veterinary Therapeutics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Veterinary Therapeutics Sales Value, 2019-2030
6.9.2 India Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Veterinary Therapeutics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Profile
7.1.2 Zoetis Main Business
7.1.3 Zoetis Veterinary Therapeutics Products, Services and Solutions
7.1.4 Zoetis Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.1.5 Zoetis Recent Developments
7.2 Elanco
7.2.1 Elanco Profile
7.2.2 Elanco Main Business
7.2.3 Elanco Veterinary Therapeutics Products, Services and Solutions
7.2.4 Elanco Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.2.5 Elanco Recent Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Profile
7.3.2 Boehringer Ingelheim Main Business
7.3.3 Boehringer Ingelheim Veterinary Therapeutics Products, Services and Solutions
7.3.4 Boehringer Ingelheim Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.3.5 Merck Recent Developments
7.4 Merck
7.4.1 Merck Profile
7.4.2 Merck Main Business
7.4.3 Merck Veterinary Therapeutics Products, Services and Solutions
7.4.4 Merck Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.4.5 Merck Recent Developments
7.5 Virbac
7.5.1 Virbac Profile
7.5.2 Virbac Main Business
7.5.3 Virbac Veterinary Therapeutics Products, Services and Solutions
7.5.4 Virbac Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.5.5 Virbac Recent Developments
7.6 Ceva
7.6.1 Ceva Profile
7.6.2 Ceva Main Business
7.6.3 Ceva Veterinary Therapeutics Products, Services and Solutions
7.6.4 Ceva Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.6.5 Ceva Recent Developments
7.7 Vetoquinol
7.7.1 Vetoquinol Profile
7.7.2 Vetoquinol Main Business
7.7.3 Vetoquinol Veterinary Therapeutics Products, Services and Solutions
7.7.4 Vetoquinol Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.7.5 Vetoquinol Recent Developments
7.8 Dechra
7.8.1 Dechra Profile
7.8.2 Dechra Main Business
7.8.3 Dechra Veterinary Therapeutics Products, Services and Solutions
7.8.4 Dechra Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.8.5 Dechra Recent Developments
7.9 Norbrook
7.9.1 Norbrook Profile
7.9.2 Norbrook Main Business
7.9.3 Norbrook Veterinary Therapeutics Products, Services and Solutions
7.9.4 Norbrook Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.9.5 Norbrook Recent Developments
7.10 Phibro
7.10.1 Phibro Profile
7.10.2 Phibro Main Business
7.10.3 Phibro Veterinary Therapeutics Products, Services and Solutions
7.10.4 Phibro Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.10.5 Phibro Recent Developments
7.11 Huvepharma
7.11.1 Huvepharma Profile
7.11.2 Huvepharma Main Business
7.11.3 Huvepharma Veterinary Therapeutics Products, Services and Solutions
7.11.4 Huvepharma Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.11.5 Huvepharma Recent Developments
7.12 Hipra
7.12.1 Hipra Profile
7.12.2 Hipra Main Business
7.12.3 Hipra Veterinary Therapeutics Products, Services and Solutions
7.12.4 Hipra Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.12.5 Hipra Recent Developments
7.13 Ouro Fino Saude
7.13.1 Ouro Fino Saude Profile
7.13.2 Ouro Fino Saude Main Business
7.13.3 Ouro Fino Saude Veterinary Therapeutics Products, Services and Solutions
7.13.4 Ouro Fino Saude Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.13.5 Ouro Fino Saude Recent Developments
7.14 CAHIC
7.14.1 CAHIC Profile
7.14.2 CAHIC Main Business
7.14.3 CAHIC Veterinary Therapeutics Products, Services and Solutions
7.14.4 CAHIC Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.14.5 CAHIC Recent Developments
7.15 Orion
7.15.1 Orion Profile
7.15.2 Orion Main Business
7.15.3 Orion Veterinary Therapeutics Products, Services and Solutions
7.15.4 Orion Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.15.5 Orion Recent Developments
7.16 Ringpu Biology
7.16.1 Ringpu Biology Profile
7.16.2 Ringpu Biology Main Business
7.16.3 Ringpu Biology Veterinary Therapeutics Products, Services and Solutions
7.16.4 Ringpu Biology Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.16.5 Ringpu Biology Recent Developments
7.17 Nippon Zenyaku Kogyo
7.17.1 Nippon Zenyaku Kogyo Profile
7.17.2 Nippon Zenyaku Kogyo Main Business
7.17.3 Nippon Zenyaku Kogyo Veterinary Therapeutics Products, Services and Solutions
7.17.4 Nippon Zenyaku Kogyo Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.17.5 Nippon Zenyaku Kogyo Recent Developments
7.18 Farmavet-Pasteur
7.18.1 Farmavet-Pasteur Profile
7.18.2 Farmavet-Pasteur Main Business
7.18.3 Farmavet-Pasteur Veterinary Therapeutics Products, Services and Solutions
7.18.4 Farmavet-Pasteur Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.18.5 Farmavet-Pasteur Recent Developments
8 Industry Chain Analysis
8.1 Veterinary Therapeutics Industrial Chain
8.2 Veterinary Therapeutics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Veterinary Therapeutics Sales Model
8.5.2 Sales Channel
8.5.3 Veterinary Therapeutics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Veterinary Therapeutics Product Introduction
1.2 Global Veterinary Therapeutics Market Size Forecast
1.3 Veterinary Therapeutics Market Trends & Drivers
1.3.1 Veterinary Therapeutics Industry Trends
1.3.2 Veterinary Therapeutics Market Drivers & Opportunity
1.3.3 Veterinary Therapeutics Market Challenges
1.3.4 Veterinary Therapeutics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Veterinary Therapeutics Players Revenue Ranking (2023)
2.2 Global Veterinary Therapeutics Revenue by Company (2019-2024)
2.3 Key Companies Veterinary Therapeutics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Veterinary Therapeutics Product Offered
2.5 Key Companies Time to Begin Mass Production of Veterinary Therapeutics
2.6 Veterinary Therapeutics Market Competitive Analysis
2.6.1 Veterinary Therapeutics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Veterinary Therapeutics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Therapeutics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Anti-Infectives
3.1.2 Anti-Inflammatory
3.1.3 Parasiticides
3.1.4 Analgesics
3.1.5 Sedatives
3.1.6 Others
3.2 Global Veterinary Therapeutics Sales Value by Type
3.2.1 Global Veterinary Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Veterinary Therapeutics Sales Value, by Type (2019-2030)
3.2.3 Global Veterinary Therapeutics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pets
4.1.2 Cattle
4.1.3 Poultry
4.1.4 Swine
4.1.5 Others
4.2 Global Veterinary Therapeutics Sales Value by Application
4.2.1 Global Veterinary Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Veterinary Therapeutics Sales Value, by Application (2019-2030)
4.2.3 Global Veterinary Therapeutics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Veterinary Therapeutics Sales Value by Region
5.1.1 Global Veterinary Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Veterinary Therapeutics Sales Value by Region (2019-2024)
5.1.3 Global Veterinary Therapeutics Sales Value by Region (2025-2030)
5.1.4 Global Veterinary Therapeutics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Veterinary Therapeutics Sales Value, 2019-2030
5.2.2 North America Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Veterinary Therapeutics Sales Value, 2019-2030
5.3.2 Europe Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Veterinary Therapeutics Sales Value, 2019-2030
5.4.2 Asia Pacific Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Veterinary Therapeutics Sales Value, 2019-2030
5.5.2 South America Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Veterinary Therapeutics Sales Value, 2019-2030
5.6.2 Middle East & Africa Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Veterinary Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Veterinary Therapeutics Sales Value
6.3 United States
6.3.1 United States Veterinary Therapeutics Sales Value, 2019-2030
6.3.2 United States Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Veterinary Therapeutics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Veterinary Therapeutics Sales Value, 2019-2030
6.4.2 Europe Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Veterinary Therapeutics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Veterinary Therapeutics Sales Value, 2019-2030
6.5.2 China Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Veterinary Therapeutics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Veterinary Therapeutics Sales Value, 2019-2030
6.6.2 Japan Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Veterinary Therapeutics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Veterinary Therapeutics Sales Value, 2019-2030
6.7.2 South Korea Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Veterinary Therapeutics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Veterinary Therapeutics Sales Value, 2019-2030
6.8.2 Southeast Asia Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Veterinary Therapeutics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Veterinary Therapeutics Sales Value, 2019-2030
6.9.2 India Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Veterinary Therapeutics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Profile
7.1.2 Zoetis Main Business
7.1.3 Zoetis Veterinary Therapeutics Products, Services and Solutions
7.1.4 Zoetis Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.1.5 Zoetis Recent Developments
7.2 Elanco
7.2.1 Elanco Profile
7.2.2 Elanco Main Business
7.2.3 Elanco Veterinary Therapeutics Products, Services and Solutions
7.2.4 Elanco Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.2.5 Elanco Recent Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Profile
7.3.2 Boehringer Ingelheim Main Business
7.3.3 Boehringer Ingelheim Veterinary Therapeutics Products, Services and Solutions
7.3.4 Boehringer Ingelheim Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.3.5 Merck Recent Developments
7.4 Merck
7.4.1 Merck Profile
7.4.2 Merck Main Business
7.4.3 Merck Veterinary Therapeutics Products, Services and Solutions
7.4.4 Merck Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.4.5 Merck Recent Developments
7.5 Virbac
7.5.1 Virbac Profile
7.5.2 Virbac Main Business
7.5.3 Virbac Veterinary Therapeutics Products, Services and Solutions
7.5.4 Virbac Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.5.5 Virbac Recent Developments
7.6 Ceva
7.6.1 Ceva Profile
7.6.2 Ceva Main Business
7.6.3 Ceva Veterinary Therapeutics Products, Services and Solutions
7.6.4 Ceva Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.6.5 Ceva Recent Developments
7.7 Vetoquinol
7.7.1 Vetoquinol Profile
7.7.2 Vetoquinol Main Business
7.7.3 Vetoquinol Veterinary Therapeutics Products, Services and Solutions
7.7.4 Vetoquinol Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.7.5 Vetoquinol Recent Developments
7.8 Dechra
7.8.1 Dechra Profile
7.8.2 Dechra Main Business
7.8.3 Dechra Veterinary Therapeutics Products, Services and Solutions
7.8.4 Dechra Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.8.5 Dechra Recent Developments
7.9 Norbrook
7.9.1 Norbrook Profile
7.9.2 Norbrook Main Business
7.9.3 Norbrook Veterinary Therapeutics Products, Services and Solutions
7.9.4 Norbrook Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.9.5 Norbrook Recent Developments
7.10 Phibro
7.10.1 Phibro Profile
7.10.2 Phibro Main Business
7.10.3 Phibro Veterinary Therapeutics Products, Services and Solutions
7.10.4 Phibro Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.10.5 Phibro Recent Developments
7.11 Huvepharma
7.11.1 Huvepharma Profile
7.11.2 Huvepharma Main Business
7.11.3 Huvepharma Veterinary Therapeutics Products, Services and Solutions
7.11.4 Huvepharma Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.11.5 Huvepharma Recent Developments
7.12 Hipra
7.12.1 Hipra Profile
7.12.2 Hipra Main Business
7.12.3 Hipra Veterinary Therapeutics Products, Services and Solutions
7.12.4 Hipra Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.12.5 Hipra Recent Developments
7.13 Ouro Fino Saude
7.13.1 Ouro Fino Saude Profile
7.13.2 Ouro Fino Saude Main Business
7.13.3 Ouro Fino Saude Veterinary Therapeutics Products, Services and Solutions
7.13.4 Ouro Fino Saude Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.13.5 Ouro Fino Saude Recent Developments
7.14 CAHIC
7.14.1 CAHIC Profile
7.14.2 CAHIC Main Business
7.14.3 CAHIC Veterinary Therapeutics Products, Services and Solutions
7.14.4 CAHIC Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.14.5 CAHIC Recent Developments
7.15 Orion
7.15.1 Orion Profile
7.15.2 Orion Main Business
7.15.3 Orion Veterinary Therapeutics Products, Services and Solutions
7.15.4 Orion Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.15.5 Orion Recent Developments
7.16 Ringpu Biology
7.16.1 Ringpu Biology Profile
7.16.2 Ringpu Biology Main Business
7.16.3 Ringpu Biology Veterinary Therapeutics Products, Services and Solutions
7.16.4 Ringpu Biology Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.16.5 Ringpu Biology Recent Developments
7.17 Nippon Zenyaku Kogyo
7.17.1 Nippon Zenyaku Kogyo Profile
7.17.2 Nippon Zenyaku Kogyo Main Business
7.17.3 Nippon Zenyaku Kogyo Veterinary Therapeutics Products, Services and Solutions
7.17.4 Nippon Zenyaku Kogyo Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.17.5 Nippon Zenyaku Kogyo Recent Developments
7.18 Farmavet-Pasteur
7.18.1 Farmavet-Pasteur Profile
7.18.2 Farmavet-Pasteur Main Business
7.18.3 Farmavet-Pasteur Veterinary Therapeutics Products, Services and Solutions
7.18.4 Farmavet-Pasteur Veterinary Therapeutics Revenue (US$ Million) & (2019-2024)
7.18.5 Farmavet-Pasteur Recent Developments
8 Industry Chain Analysis
8.1 Veterinary Therapeutics Industrial Chain
8.2 Veterinary Therapeutics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Veterinary Therapeutics Sales Model
8.5.2 Sales Channel
8.5.3 Veterinary Therapeutics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Veterinary Therapeutics Market Trends
Table 2. Veterinary Therapeutics Market Drivers & Opportunity
Table 3. Veterinary Therapeutics Market Challenges
Table 4. Veterinary Therapeutics Market Restraints
Table 5. Global Veterinary Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Veterinary Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Veterinary Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Veterinary Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Veterinary Therapeutics
Table 10. Global Veterinary Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Veterinary Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Veterinary Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Veterinary Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Veterinary Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Veterinary Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Veterinary Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Veterinary Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Veterinary Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Veterinary Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Veterinary Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Veterinary Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Veterinary Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Veterinary Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Veterinary Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Veterinary Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Veterinary Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Veterinary Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Veterinary Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Zoetis Basic Information List
Table 32. Zoetis Description and Business Overview
Table 33. Zoetis Veterinary Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Veterinary Therapeutics Business of Zoetis (2019-2024)
Table 35. Zoetis Recent Developments
Table 36. Elanco Basic Information List
Table 37. Elanco Description and Business Overview
Table 38. Elanco Veterinary Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Veterinary Therapeutics Business of Elanco (2019-2024)
Table 40. Elanco Recent Developments
Table 41. Boehringer Ingelheim Basic Information List
Table 42. Boehringer Ingelheim Description and Business Overview
Table 43. Boehringer Ingelheim Veterinary Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Veterinary Therapeutics Business of Boehringer Ingelheim (2019-2024)
Table 45. Boehringer Ingelheim Recent Developments
Table 46. Merck Basic Information List
Table 47. Merck Description and Business Overview
Table 48. Merck Veterinary Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Veterinary Therapeutics Business of Merck (2019-2024)
Table 50. Merck Recent Developments
Table 51. Virbac Basic Information List
Table 52. Virbac Description and Business Overview
Table 53. Virbac Veterinary Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Veterinary Therapeutics Business of Virbac (2019-2024)
Table 55. Virbac Recent Developments
Table 56. Ceva Basic Information List
Table 57. Ceva Description and Business Overview
Table 58. Ceva Veterinary Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Veterinary Therapeutics Business of Ceva (2019-2024)
Table 60. Ceva Recent Developments
Table 61. Vetoquinol Basic Information List
Table 62. Vetoquinol Description and Business Overview
Table 63. Vetoquinol Veterinary Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Veterinary Therapeutics Business of Vetoquinol (2019-2024)
Table 65. Vetoquinol Recent Developments
Table 66. Dechra Basic Information List
Table 67. Dechra Description and Business Overview
Table 68. Dechra Veterinary Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Veterinary Therapeutics Business of Dechra (2019-2024)
Table 70. Dechra Recent Developments
Table 71. Norbrook Basic Information List
Table 72. Norbrook Description and Business Overview
Table 73. Norbrook Veterinary Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Veterinary Therapeutics Business of Norbrook (2019-2024)
Table 75. Norbrook Recent Developments
Table 76. Phibro Basic Information List
Table 77. Phibro Description and Business Overview
Table 78. Phibro Veterinary Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Veterinary Therapeutics Business of Phibro (2019-2024)
Table 80. Phibro Recent Developments
Table 81. Huvepharma Basic Information List
Table 82. Huvepharma Description and Business Overview
Table 83. Huvepharma Veterinary Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Veterinary Therapeutics Business of Huvepharma (2019-2024)
Table 85. Huvepharma Recent Developments
Table 86. Hipra Basic Information List
Table 87. Hipra Description and Business Overview
Table 88. Hipra Veterinary Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Veterinary Therapeutics Business of Hipra (2019-2024)
Table 90. Hipra Recent Developments
Table 91. Ouro Fino Saude Basic Information List
Table 92. Ouro Fino Saude Description and Business Overview
Table 93. Ouro Fino Saude Veterinary Therapeutics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Veterinary Therapeutics Business of Ouro Fino Saude (2019-2024)
Table 95. Ouro Fino Saude Recent Developments
Table 96. CAHIC Basic Information List
Table 97. CAHIC Description and Business Overview
Table 98. CAHIC Veterinary Therapeutics Products, Services and Solutions
Table 99. Revenue (US$ Million) in Veterinary Therapeutics Business of CAHIC (2019-2024)
Table 100. CAHIC Recent Developments
Table 101. Orion Basic Information List
Table 102. Orion Description and Business Overview
Table 103. Orion Veterinary Therapeutics Products, Services and Solutions
Table 104. Revenue (US$ Million) in Veterinary Therapeutics Business of Orion (2019-2024)
Table 105. Orion Recent Developments
Table 106. Ringpu Biology Basic Information List
Table 107. Ringpu Biology Description and Business Overview
Table 108. Ringpu Biology Veterinary Therapeutics Products, Services and Solutions
Table 109. Revenue (US$ Million) in Veterinary Therapeutics Business of Ringpu Biology (2019-2024)
Table 110. Ringpu Biology Recent Developments
Table 111. Nippon Zenyaku Kogyo Basic Information List
Table 112. Nippon Zenyaku Kogyo Description and Business Overview
Table 113. Nippon Zenyaku Kogyo Veterinary Therapeutics Products, Services and Solutions
Table 114. Revenue (US$ Million) in Veterinary Therapeutics Business of Nippon Zenyaku Kogyo (2019-2024)
Table 115. Nippon Zenyaku Kogyo Recent Developments
Table 116. Farmavet-Pasteur Basic Information List
Table 117. Farmavet-Pasteur Description and Business Overview
Table 118. Farmavet-Pasteur Veterinary Therapeutics Products, Services and Solutions
Table 119. Revenue (US$ Million) in Veterinary Therapeutics Business of Farmavet-Pasteur (2019-2024)
Table 120. Farmavet-Pasteur Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Veterinary Therapeutics Downstream Customers
Table 124. Veterinary Therapeutics Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Veterinary Therapeutics Product Picture
Figure 2. Global Veterinary Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Veterinary Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Veterinary Therapeutics Report Years Considered
Figure 5. Global Veterinary Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Veterinary Therapeutics Revenue in 2023
Figure 7. Veterinary Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Anti-Infectives Picture
Figure 9. Anti-Inflammatory Picture
Figure 10. Parasiticides Picture
Figure 11. Analgesics Picture
Figure 12. Sedatives Picture
Figure 13. Others Picture
Figure 14. Global Veterinary Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Veterinary Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Pets
Figure 17. Product Picture of Cattle
Figure 18. Product Picture of Poultry
Figure 19. Product Picture of Swine
Figure 20. Product Picture of Others
Figure 21. Global Veterinary Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Veterinary Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 23. North America Veterinary Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 25. Europe Veterinary Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 27. Asia Pacific Veterinary Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia Pacific Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 29. South America Veterinary Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 30. South America Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Veterinary Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 33. Key Countries/Regions Veterinary Therapeutics Sales Value (%), (2019-2030)
Figure 34. United States Veterinary Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 35. United States Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 36. United States Veterinary Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 37. Europe Veterinary Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 38. Europe Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 39. Europe Veterinary Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 40. China Veterinary Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 41. China Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 42. China Veterinary Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 43. Japan Veterinary Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 44. Japan Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 45. Japan Veterinary Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 46. South Korea Veterinary Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 47. South Korea Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 48. South Korea Veterinary Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 49. Southeast Asia Veterinary Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 51. Southeast Asia Veterinary Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 52. India Veterinary Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 53. India Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 54. India Veterinary Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 55. Veterinary Therapeutics Industrial Chain
Figure 56. Veterinary Therapeutics Manufacturing Cost Structure
Figure 57. Channels of Distribution (Direct Sales, and Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Table 1. Veterinary Therapeutics Market Trends
Table 2. Veterinary Therapeutics Market Drivers & Opportunity
Table 3. Veterinary Therapeutics Market Challenges
Table 4. Veterinary Therapeutics Market Restraints
Table 5. Global Veterinary Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Veterinary Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Veterinary Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Veterinary Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Veterinary Therapeutics
Table 10. Global Veterinary Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Veterinary Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Veterinary Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Veterinary Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Veterinary Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Veterinary Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Veterinary Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Veterinary Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Veterinary Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Veterinary Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Veterinary Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Veterinary Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Veterinary Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Veterinary Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Veterinary Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Veterinary Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Veterinary Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Veterinary Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Veterinary Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Zoetis Basic Information List
Table 32. Zoetis Description and Business Overview
Table 33. Zoetis Veterinary Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Veterinary Therapeutics Business of Zoetis (2019-2024)
Table 35. Zoetis Recent Developments
Table 36. Elanco Basic Information List
Table 37. Elanco Description and Business Overview
Table 38. Elanco Veterinary Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Veterinary Therapeutics Business of Elanco (2019-2024)
Table 40. Elanco Recent Developments
Table 41. Boehringer Ingelheim Basic Information List
Table 42. Boehringer Ingelheim Description and Business Overview
Table 43. Boehringer Ingelheim Veterinary Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Veterinary Therapeutics Business of Boehringer Ingelheim (2019-2024)
Table 45. Boehringer Ingelheim Recent Developments
Table 46. Merck Basic Information List
Table 47. Merck Description and Business Overview
Table 48. Merck Veterinary Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Veterinary Therapeutics Business of Merck (2019-2024)
Table 50. Merck Recent Developments
Table 51. Virbac Basic Information List
Table 52. Virbac Description and Business Overview
Table 53. Virbac Veterinary Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Veterinary Therapeutics Business of Virbac (2019-2024)
Table 55. Virbac Recent Developments
Table 56. Ceva Basic Information List
Table 57. Ceva Description and Business Overview
Table 58. Ceva Veterinary Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Veterinary Therapeutics Business of Ceva (2019-2024)
Table 60. Ceva Recent Developments
Table 61. Vetoquinol Basic Information List
Table 62. Vetoquinol Description and Business Overview
Table 63. Vetoquinol Veterinary Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Veterinary Therapeutics Business of Vetoquinol (2019-2024)
Table 65. Vetoquinol Recent Developments
Table 66. Dechra Basic Information List
Table 67. Dechra Description and Business Overview
Table 68. Dechra Veterinary Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Veterinary Therapeutics Business of Dechra (2019-2024)
Table 70. Dechra Recent Developments
Table 71. Norbrook Basic Information List
Table 72. Norbrook Description and Business Overview
Table 73. Norbrook Veterinary Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Veterinary Therapeutics Business of Norbrook (2019-2024)
Table 75. Norbrook Recent Developments
Table 76. Phibro Basic Information List
Table 77. Phibro Description and Business Overview
Table 78. Phibro Veterinary Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Veterinary Therapeutics Business of Phibro (2019-2024)
Table 80. Phibro Recent Developments
Table 81. Huvepharma Basic Information List
Table 82. Huvepharma Description and Business Overview
Table 83. Huvepharma Veterinary Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Veterinary Therapeutics Business of Huvepharma (2019-2024)
Table 85. Huvepharma Recent Developments
Table 86. Hipra Basic Information List
Table 87. Hipra Description and Business Overview
Table 88. Hipra Veterinary Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Veterinary Therapeutics Business of Hipra (2019-2024)
Table 90. Hipra Recent Developments
Table 91. Ouro Fino Saude Basic Information List
Table 92. Ouro Fino Saude Description and Business Overview
Table 93. Ouro Fino Saude Veterinary Therapeutics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Veterinary Therapeutics Business of Ouro Fino Saude (2019-2024)
Table 95. Ouro Fino Saude Recent Developments
Table 96. CAHIC Basic Information List
Table 97. CAHIC Description and Business Overview
Table 98. CAHIC Veterinary Therapeutics Products, Services and Solutions
Table 99. Revenue (US$ Million) in Veterinary Therapeutics Business of CAHIC (2019-2024)
Table 100. CAHIC Recent Developments
Table 101. Orion Basic Information List
Table 102. Orion Description and Business Overview
Table 103. Orion Veterinary Therapeutics Products, Services and Solutions
Table 104. Revenue (US$ Million) in Veterinary Therapeutics Business of Orion (2019-2024)
Table 105. Orion Recent Developments
Table 106. Ringpu Biology Basic Information List
Table 107. Ringpu Biology Description and Business Overview
Table 108. Ringpu Biology Veterinary Therapeutics Products, Services and Solutions
Table 109. Revenue (US$ Million) in Veterinary Therapeutics Business of Ringpu Biology (2019-2024)
Table 110. Ringpu Biology Recent Developments
Table 111. Nippon Zenyaku Kogyo Basic Information List
Table 112. Nippon Zenyaku Kogyo Description and Business Overview
Table 113. Nippon Zenyaku Kogyo Veterinary Therapeutics Products, Services and Solutions
Table 114. Revenue (US$ Million) in Veterinary Therapeutics Business of Nippon Zenyaku Kogyo (2019-2024)
Table 115. Nippon Zenyaku Kogyo Recent Developments
Table 116. Farmavet-Pasteur Basic Information List
Table 117. Farmavet-Pasteur Description and Business Overview
Table 118. Farmavet-Pasteur Veterinary Therapeutics Products, Services and Solutions
Table 119. Revenue (US$ Million) in Veterinary Therapeutics Business of Farmavet-Pasteur (2019-2024)
Table 120. Farmavet-Pasteur Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Veterinary Therapeutics Downstream Customers
Table 124. Veterinary Therapeutics Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Veterinary Therapeutics Product Picture
Figure 2. Global Veterinary Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Veterinary Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Veterinary Therapeutics Report Years Considered
Figure 5. Global Veterinary Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Veterinary Therapeutics Revenue in 2023
Figure 7. Veterinary Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Anti-Infectives Picture
Figure 9. Anti-Inflammatory Picture
Figure 10. Parasiticides Picture
Figure 11. Analgesics Picture
Figure 12. Sedatives Picture
Figure 13. Others Picture
Figure 14. Global Veterinary Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Veterinary Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Pets
Figure 17. Product Picture of Cattle
Figure 18. Product Picture of Poultry
Figure 19. Product Picture of Swine
Figure 20. Product Picture of Others
Figure 21. Global Veterinary Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Veterinary Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 23. North America Veterinary Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 25. Europe Veterinary Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 27. Asia Pacific Veterinary Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia Pacific Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 29. South America Veterinary Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 30. South America Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Veterinary Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Veterinary Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 33. Key Countries/Regions Veterinary Therapeutics Sales Value (%), (2019-2030)
Figure 34. United States Veterinary Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 35. United States Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 36. United States Veterinary Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 37. Europe Veterinary Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 38. Europe Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 39. Europe Veterinary Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 40. China Veterinary Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 41. China Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 42. China Veterinary Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 43. Japan Veterinary Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 44. Japan Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 45. Japan Veterinary Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 46. South Korea Veterinary Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 47. South Korea Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 48. South Korea Veterinary Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 49. Southeast Asia Veterinary Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 51. Southeast Asia Veterinary Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 52. India Veterinary Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 53. India Veterinary Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 54. India Veterinary Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 55. Veterinary Therapeutics Industrial Chain
Figure 56. Veterinary Therapeutics Manufacturing Cost Structure
Figure 57. Channels of Distribution (Direct Sales, and Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232